Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice

Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside

(2013) Jaime E. C. Hallak et al.   JAMA Psychiatry

Structure and Regulation of Soluble Guanylate Cyclase

(2012) Emily R. Derbyshire et al.   Annual Review of Biochemistry

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

(2012) Oliver D. Howes et al.   ARCHIVES OF GENERAL PSYCHIATRY

Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy

(2012) Hans-Gert Bernstein et al.   CNS & Neurological Disorders-Drug Targets

Nitric oxide modulates apomorphine-induced recognition memory deficits in rats

(2012) Ioannis Gourgiotis et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement

(2012) Ali Hosseini-Sharifabad et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Nitric Oxide Donors Enhance the Frequency Dependence of Dopamine Release in Nucleus Accumbens

(2011) Henrike Hartung et al.   NEUROPSYCHOPHARMACOLOGY

Glutamate signaling in the pathophysiology and therapy of schizophrenia

(2011) Chieh-Hsin Lin et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models

(2011) M. Pereira et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Nitric oxide synthase inhibitors improve prepulse inhibition responses of Wistar rats

(2010) A.C. Issy et al.   BEHAVIOURAL BRAIN RESEARCH

Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia

(2010) Barbara Picconi et al.   BRAIN

Mouse behavioral endophenotypes for schizophrenia

(2010) Laura C. Amann et al.   BRAIN RESEARCH BULLETIN

Nitric oxide modulates dopaminergic regulation of prepulse inhibition in the basolateral amygdala

(2010) C Salum et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

(2010) Shahin Akhondzadeh et al.   PSYCHOPHARMACOLOGY

Neonatal ventral hippocampus lesion induces increase in no levels which is attenuated by subchronic haloperidol treatment

(2010) José Vicente Negrete-Díaz et al.   SYNAPSE

Identification of a Schizophrenia-Associated Functional Noncoding Variant inNOS1AP

(2009) Naomi S. Wratten et al.   AMERICAN JOURNAL OF PSYCHIATRY

Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice

(2009) A.C. Issy et al.   BEHAVIOURAL BRAIN RESEARCH

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

(2009) S. M. Grauer et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Developmental or adulthood overexpression of Gαs, a G-protein subunit genetically linked to schizophrenia, is sufficient to cause enlarged lateral ventricles and a smaller dorsal and ventral striatum in adult mice

(2009) M P Kelly et al.   MOLECULAR PSYCHIATRY

Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A

(2009) Christine A. Strick et al.   NEUROPHARMACOLOGY

Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats

(2009) Kris Rutten et al.   NEUROPSYCHOPHARMACOLOGY

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

(2009) O. D. Howes et al.   SCHIZOPHRENIA BULLETIN

Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons

(2008) Cristiane Salum et al.   BRAIN RESEARCH

The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging

(2008) K. Domek-Łopacińska et al.   BRAIN RESEARCH

The Role of Phosphodiesterases in Schizophrenia

(2008) Judith A Siuciak   CNS DRUGS

Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle

(2008) T. B. Halene et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

(2008) C. J. Schmidt et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine

(2008) M. Weber et al.   PSYCHOPHARMACOLOGY

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

(2008) Donald C. Goff et al.   PSYCHOPHARMACOLOGY